Cargando…

Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study

BACKGROUND: The feasibility of liver transplantation (LT) in elderly recipients remains a topic of debate. METHODS: This cohort study evaluated the impact of recipient's age on LT outcome between January 2007 and May 2016 covered by the Korean National Health Insurance system (n = 9415). Multil...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil, Eunmi, Kim, Jong Man, Jeon, Kyeongman, Park, Hyejeong, Kang, Danbee, Cho, Juhee, Suh, Gee Young, Park, Jinkyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257104/
https://www.ncbi.nlm.nih.gov/pubmed/30153223
http://dx.doi.org/10.1097/TP.0000000000002246
_version_ 1783374261896871936
author Gil, Eunmi
Kim, Jong Man
Jeon, Kyeongman
Park, Hyejeong
Kang, Danbee
Cho, Juhee
Suh, Gee Young
Park, Jinkyeong
author_facet Gil, Eunmi
Kim, Jong Man
Jeon, Kyeongman
Park, Hyejeong
Kang, Danbee
Cho, Juhee
Suh, Gee Young
Park, Jinkyeong
author_sort Gil, Eunmi
collection PubMed
description BACKGROUND: The feasibility of liver transplantation (LT) in elderly recipients remains a topic of debate. METHODS: This cohort study evaluated the impact of recipient's age on LT outcome between January 2007 and May 2016 covered by the Korean National Health Insurance system (n = 9415). Multilevel regression models were used to determine the impact of recipient's age on in-hospital and long-term mortality after LT. RESULTS: All patients had a first LT, with 2473 transplanted with liver from deceased donors (DD) and 6942 from living donors. The mean age was 52.2 ± 9.0 years. Most LT were performed on patients in their 50s (n = 4290, 45.6%) and 0.9% (n = 84) of the LT was performed on patients older 70 years. The overall in-hospital mortality was 6.3%, and the 3-year mortality was 11.3%. The in-hospital mortality included, 13.5% associated with DDLT and 3.7% involved living donor LT. When compared with that for patients aged 51 to 55 years, the risk of death among recipients older than 70 years was about fourfold higher after adjusting for baseline liver disease (odds ratio, 4.1; 95% confidence interval, 2.21-7.58), and was nearly threefold higher after adjusting for baseline liver disease and perioperative complications (odds ratio, 2.92; 95% confidence interval, 1.37-6.24). Also, the cost of LT increased significantly with age. CONCLUSIONS: The data show that age remains an important risk factor for LT, suggesting that LT should be considered with caution in elderly recipients.
format Online
Article
Text
id pubmed-6257104
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-62571042019-03-06 Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study Gil, Eunmi Kim, Jong Man Jeon, Kyeongman Park, Hyejeong Kang, Danbee Cho, Juhee Suh, Gee Young Park, Jinkyeong Transplantation Original Clinical Science—Liver BACKGROUND: The feasibility of liver transplantation (LT) in elderly recipients remains a topic of debate. METHODS: This cohort study evaluated the impact of recipient's age on LT outcome between January 2007 and May 2016 covered by the Korean National Health Insurance system (n = 9415). Multilevel regression models were used to determine the impact of recipient's age on in-hospital and long-term mortality after LT. RESULTS: All patients had a first LT, with 2473 transplanted with liver from deceased donors (DD) and 6942 from living donors. The mean age was 52.2 ± 9.0 years. Most LT were performed on patients in their 50s (n = 4290, 45.6%) and 0.9% (n = 84) of the LT was performed on patients older 70 years. The overall in-hospital mortality was 6.3%, and the 3-year mortality was 11.3%. The in-hospital mortality included, 13.5% associated with DDLT and 3.7% involved living donor LT. When compared with that for patients aged 51 to 55 years, the risk of death among recipients older than 70 years was about fourfold higher after adjusting for baseline liver disease (odds ratio, 4.1; 95% confidence interval, 2.21-7.58), and was nearly threefold higher after adjusting for baseline liver disease and perioperative complications (odds ratio, 2.92; 95% confidence interval, 1.37-6.24). Also, the cost of LT increased significantly with age. CONCLUSIONS: The data show that age remains an important risk factor for LT, suggesting that LT should be considered with caution in elderly recipients. Lippincott Williams & Wilkins 2018-12 2018-11-21 /pmc/articles/PMC6257104/ /pubmed/30153223 http://dx.doi.org/10.1097/TP.0000000000002246 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Clinical Science—Liver
Gil, Eunmi
Kim, Jong Man
Jeon, Kyeongman
Park, Hyejeong
Kang, Danbee
Cho, Juhee
Suh, Gee Young
Park, Jinkyeong
Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study
title Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study
title_full Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study
title_fullStr Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study
title_full_unstemmed Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study
title_short Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study
title_sort recipient age and mortality after liver transplantation: a population-based cohort study
topic Original Clinical Science—Liver
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257104/
https://www.ncbi.nlm.nih.gov/pubmed/30153223
http://dx.doi.org/10.1097/TP.0000000000002246
work_keys_str_mv AT gileunmi recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy
AT kimjongman recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy
AT jeonkyeongman recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy
AT parkhyejeong recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy
AT kangdanbee recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy
AT chojuhee recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy
AT suhgeeyoung recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy
AT parkjinkyeong recipientageandmortalityafterlivertransplantationapopulationbasedcohortstudy